登录

Delta Medical Nabs Tens of Million Yuan C Round of Financing

作者: Mailman 2019-08-22 17:17
德益达美医疗
http://www.deltamedical.cn
企业数据由 动脉橙 提供支持
骨科手术器械及康复类医疗器械研发商 | 未公开 | 运营中
中国-北京
查看

On August 16,  Beijing Delta Medical ("Delta Medical"), a company specializing in sports medicine devices and sports rehabilitation services,  has launched tens of million yuan C round of financing. This round of financing was led by Qiming Ventures, followed by Bohang Capital.


Delta Medical is dedicated to sports medicine surgery, providing a full range of arthroscopic devices covering, suture anchors, interference screws, buttons, ultra-high-strength suture without needles, arthroscopic instrument sets, as well as postsurgical and rehabilitation braces. It is the first medical device company in China that focuses on the independent R&D, production and sales of sports medicine products.


"This round of financing will provide a stronger barrier for the company's core product development and marketing, and also help the company to build a more robust business environment," said Li Jianbo, the co-founder and general manager of Delta Medical.


Delta Medical has a number of international patents, and many products have obtained provincial and municipal certificates, and it is committed to providing various integrated sports medicine treatment solutions. 


Delta Medical has reached a cooperative relationship with more than 500 customers and institutions at home and abroad.  Also, the international certification and registration process is proceeding. "In 2019, the sales of Delta Medical is expected to reach tens of million yuan," Li Jianbo added. 


>>>>

About Qiming Ventures


Founded in 2006, Qiming is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Shenzhen and Hong Kong. In 2017, Qiming raised its first US fund and set up Qiming’s US offices in Seattle, Boston and Palo Alto. Currently, Qiming manages seven US Dollar funds and five RMB funds with US$4 billion assets under management.

注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

【首发】打造全球首创心脏“四维”标测系统,电生理全球创新平台企业心航路医学完成2亿元首轮超募融资,龙磐投资和礼来亚洲基金联合领投

【首发】垦拓流体完成超亿元C轮融资,破解精密微流体控制元件卡脖子难题

【首发】破局国外垄断,加速国产心腔内超声(ICE)进程!心寰科技完成天使轮融资

【首发】脉搏医疗完成C轮融资,构筑结构性心脏病高端医疗器械创新平台

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Yaoyanshe Completed 300 Million Yuan C Round of Financing

2019-08-22
下一篇

肿瘤免疫公司Oncorus完成7950万美元B轮融资,推进下一代溶瘤病毒治疗

2019-08-22